EIA
ABBV icon

Eastover Investment Advisors’s AbbVie ABBV Stock Holding History

Eastover Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.06M Buy
35,999
+436
+1% +$93.8K 3.57% 11
2026
Q1 		$7.73M Buy
35,563
+417
+1% +$92.5K 3.31% 15
2025
Q4 		$8.03M Sell
35,146
-138
-0.4% -$31.4K 3.53% 11
2025
Q3 		$8.17M Sell
35,284
-2,165
-6% -$441K 3.55% 12
2025
Q2 		$6.95M Buy
37,449
+403
+1% +$74.9K 3.12% 19
2025
Q1 		$7.76M Sell
37,046
-329
-0.9% -$64K 3.75% 13
2024
Q4 		$6.64M Sell
37,375
-682
-2% -$125K 3.11% 18
2024
Q3 		$7.52M Buy
38,057
+1,183
+3% +$221K 3.52% 15
2024
Q2 		$6.12M Buy
36,874
+446
+1% +$73.9K 2.93% 15
2024
Q1 		$6.63M Sell
36,428
-515
-1% -$88.8K 3.24% 12
2023
Q4 		$5.73M Buy
36,943
+1,146
+3% +$167K 3.03% 20
2023
Q3 		$5.34M Buy
35,797
+664
+2% +$97.5K 3.21% 15
2023
Q2 		$4.73M Sell
35,133
-4,140
-11% -$607K 2.53% 24
2023
Q1 		$6.26M Buy
39,273
+277
+0.7% +$42.3K 3.5% 9
2022
Q4 		$6.3M Buy
38,996
+293
+0.8% +$44.9K 3.61% 8
2022
Q3 		$5.37M Buy
38,703
+418
+1% +$60K 3.35% 10
2022
Q2 		$5.86M Sell
38,285
-14,420
-27% -$2.2M 3.58% 9
2022
Q1 		$8.54M Buy
52,705
+3,845
+8% +$559K 4.51% 3
2021
Q4 		$6.62M Buy
48,860
+719
+1% +$84.9K 3.82% 5
2021
Q3 		$5.19M Buy
48,141
+565
+1% +$64.6K 3.38% 9
2021
Q2 		$5.36M Buy
47,576
+2,085
+5% +$235K 3.48% 8
2021
Q1 		$4.92M Sell
45,491
-3,151
-6% -$337K 3.48% 11
2020
Q4 		$5.21M Sell
48,642
-230
-0.5% -$22.1K 3.61% 7
2020
Q3 		$4.28M Buy
48,872
+755
+2% +$71.1K 3.25% 11
2020
Q2 		$4.72M Buy
48,117
+844
+2% +$74.3K 3.9% 5
2020
Q1 		$3.6M Buy
+47,273
New +$4.03M 3.49% 8

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Eastover Investment Advisors's ABBV Position: Q2 2026 in Review

Eastover Investment Advisors increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $93.8K and bringing the position to 35,999 shares worth $9.06M. The position accounts for 3.57% of the portfolio, ranked #11.

Eastover Investment Advisors first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eastover Investment Advisors held 35,999 shares of AbbVie worth $9.06M as of Q2 2026.
  • Eastover Investment Advisors bought 436 AbbVie shares in Q2 2026, an estimated $93.8K.
  • AbbVie made up 3.57% of Eastover Investment Advisors's portfolio in Q2 2026, its #11 holding.
  • Eastover Investment Advisors first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eastover Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.